blue care network glp-1 coverage 2025 change for drugs to treat obesity bcbs glp-1 coverage GLP-1 Drugs:

So the drug may simply be bringing out a problem that was already brewing, rather than creating a brand new one

DENVER, June 16, 2026--Virta Health, the leader in metabolic disease reversal, today released its third annual 2026 Virta Vitals, a national survey of U.S

Glucagon-like peptide 1 (GLP1) analogues are licensed options for obesity, but new treatments are required to obtain better weight loss and to directly address other co-morbidities, such as non-alcoholic fatty liver disease

Follow the incentives

The change, advocates argue, would curb rising obesity rates, reduce health care disparities and save on health care costs.